CLS

Celestica Inc.

$304.61

+1.64% Oct 21 close

Technology Compare

1M 3M 6M 1Y 2Y

CLSSPY

-5.8%

-11.6%

-9.2%

-24.2%

YTD

+3.0%

+15.1%

Live chart

Loading live chart…

What they do

Celestica Inc. provides supply chain solutions in Asia, North America, and internationally. It operates through two segments, Advanced Technology Solutions, and Connectivity and Cloud Solutions. The company offers a range of product manufacturing and related supply chain services, including design and development, new product introduction, engineering services.

Technology · Electronic Components

For information only · Important disclosures

Grades vs sector

No sector grades for CLS yet. Grades rank S&P 1500 stocks within their sector and refresh after each daily data run, so a stock outside that index or newly covered has none.

Our models

Not held by any of our 5 live models right now.

Quality Growth

Outside this model's universe or screens

Momentum Top 15

Outside this model's universe or screens

Momentum Blend

Not in the current book

New Highs Growth

Outside this model's universe or screens

Coteau Long Book

Not in the current book

News

More news

Zacks · 17h ago

Can EPC Power Acquisition Boost Flex's AI Infrastructure Growth?

Zacks · Oct 20

Celestica Heads These 3 Canadian Undervalued Stocks

Simply Wall St. · Oct 19

Celestica (CLS) Stock Dips While Market Gains: Key Facts

Zacks · Oct 19

3 Canadian Growth Stocks To Own In October 2026

Simply Wall St. · Oct 16

Key stats

Market value$38.4B

P/E (last 12 months)31.6

P/E (next 12 months, estimated)15.5

52-week range$244.51 – $474.03

Revenue growth (latest quarter vs a year ago)+62.4%

Dividend yieldNo dividend

Analyst consensusStrong Buy (18)

Average analyst price target$473.91 (+56%)

Valuation and fundamentals

Valuation & fundamentals

Bottom line

Looks undervalued

Model read-out from the numbers below, not advice. Score +4 (DCF counts double).

▲DCF (base case)above the price by 56%

▲Piotroski F-score7/9

▲Altman Z5.4 (safe)

▲Net debt / EBITDA-0.3x

▲Analyst target+56% (18 analysts)

Discounted cash flow

Bear

$220

-28%

growth 18% · disc. 11.8% · term. 2.0%

Base

$474

+56%

growth 30% · disc. 10.8% · term. 2.5%

Bull

$847

+178%

growth 38% · disc. 9.8% · term. 3.0%

A DCF starts from trailing free cash flow, so it can overstate value if the last 12 months were unusually strong (or weak). Use the bear case or edit the starting cash flow if so.

Reverse DCFfor context, not a signal

Today's price assumes free cash flow grows about 16% a year for 10 years.

Implied

+16%/yr

FCF, last 3 yrs

+46%/yr

FCF, last 5 yrs

n/a

Revenue, last 3 yrs

+20%/yr

Revenue, last 5 yrs

n/a

Same inputs as the DCF above: trailing free cash flow 1.1B, 10.8% discount rate, 2.5% growth after year 10, net cash and today's share count. Actual growth rates are compound annual rates from SEC annual filings through FY2025; "n/a" means too little history or a negative starting year.

Edit assumptions · recalculates instantly

Your value per share–

Free cash flow = operating cash flow − capital spending, trailing 12 months (TTM to 2026-06-30). Growth default: average of 3-year revenue CAGR and latest revenue growth, capped at 30%. Years 6–10 fade linearly to terminal growth. Discount rate = 4.25% risk-free assumption + beta 1.32 × 5% equity premium, kept within 7–13%. Bear: lower growth, +1 pt discount, 2% terminal. Bull: higher growth, −1 pt, 3%.

Multiples vs sector

Forward EPS $19.67 vs trailing $9.63 (+104% expected growth). Forward P/E uses analysts' next-12-month estimate.

Quality & financial health

Gross margin

12.0%

Operating margin

8.8%

FCF margin

7.3%

Net margin

7.2%

Return on equity

45.0%

Return on invested capital

60.0%

Net debt / EBITDA

-0.3×

Current ratio

1.2×

Interest cover

22.0×

Cash conversion (OCF/NI)

1.0×

Piotroski F-score 7/9 · last two fiscal years

✓ Positive net income✓ Positive operating cash flow✓ Return on assets improved✗ Cash flow above net income✓ Long-term debt / assets fell✗ Current ratio improved✓ No share dilution✓ Gross margin improved✓ Asset turnover improved

Altman Z-score 5.4 (safe zone; above 3.0 = safe, below 1.8 = distress). Not meaningful for banks and insurers.

Analysts

Mean target

$474

+56%

Analysts

Strong Buy

Range

$375–$550

low – high

● price · ◆ mean target

Annual history

FY	Revenue	Net income	Free cash flow
2025	$12.4B	$832.5M	$659.5M
2024	$9.6B	$428.0M	$473.9M
2023	$8.0B	$244.4M	$326.2M
2022	$7.2B	$180.1M	$211.1M

From the company's 10-K filings via SEC XBRL. 3-year revenue CAGR +19.6%.

Earnings

Next report: 2026-10-26 · after close · EPS est 2.97

EstimateActual (beat)Actual (miss)

Report	EPS est	Actual	Surprise
2026-07-27	2.31	2.54	+10.0%
2026-04-27	2.07	2.16	+4.4%
2026-01-28	1.76	1.89	+7.3%
2025-10-27	1.49	1.58	+6.0%
2025-07-28	1.23	1.39	+12.7%
2025-04-24	1.12	1.20	+7.6%
2025-01-29	1.06	1.11	+5.1%
2024-10-23	0.94	1.04	+11.1%

Quarterly revenue

Quarter	Revenue	YoY
2026-06-30	$4.7B	+62.4%
2026-03-31	$4.0B	–
2025-12-31	$3.7B	–
2025-09-30	$3.2B	–
2025-06-30	$2.9B	–

Analyst actions

Bernstein

2026-09-30 · init

→ Outperform
PT $520

FBN Securities

2026-09-15 · init

→ Outperform
PT $375

UBS

2026-08-24 · up

Neutral → Buy
PT $430

Barclays

2026-08-07 · main

Overweight → Overweight
PT $406

JP Morgan

2026-07-29 · main

Overweight → Overweight
PT $485

Wolfe Research

2026-07-29 · main

Outperform → Outperform
PT $475

Insider trades

Mionis Robert